Our findings confirm the major increase in the global amount of circulating ASC in active SLE, while also provide the first evidence of a substantial expansion of CD138+ cells lacking CD19 expression, a phenotype typically ascribed to mature BM LLPC1,10. This evidence concerns the gene CD19 and systemic lupus erythematosus.